They accuse their neurologists and the French drug manufacturer Sanofi, which produces Depakine, of failing to warn them about the risks to the fetus, according to reports published on Le Matin Dimanche and SonntagsZeitung.
Depakine is still widely used today to treat epilepsy and migraines. Scientists have established that the sodium valproate contained in the drug creates psychomotor, cognitive and mental development disorders in 30 to 40% of cases.
The Swiss expecting mothers were not made aware of these dangers. A warning from agency for therapeutic products, Swissmedic, came to late.
In Switzerland, 39 children have been born with brain damage in connection to Depakine use, according to a report commissioned by the government.
Thierry Buclin, a professor of clinical pharmacology at the University Hospital of Lausanne suspects the actual figure is much higher.
The professors, who was quoted in the media reports, says the government study is incomplete. It does not consider the transgenerational effect of Depakin which has been brought to light by recent scientific studies.
The controversial drug has been authorised in Switzerland since the 1970s. Such side effects were not mentioned in the package leaflet until 2015.
In neighbouring France, as many as 6,500 children have been negatively affected by Depakine. The victims launched a collective action against Sanofi at the end of 2016 to obtain compensation.
The first complaint was made in Switzerland in 2017 by a woman who had been using the drug since adolescence and even had her dosage raised by her neurologist during one of her pregnancies. She gave birth to two children who suffer from severe cognitive disorders and autism.
Train vs plane: would you take a direct train between London and Geneva?
Eurostar is planning to run direct trains from Britain to Germany and Switzerland from the early 2030s. Would you favour the train over the plane? If not, why not?
Swiss voters to decide on three issues on November 30
This content was published on
Compulsory service for all, a tax on million-dollar inheritances, more indirect subsidies for media publishers: the electorate can vote on these three national issues on November 30.
Dollar falls to lowest level against franc in 14 years
This content was published on
The weakness of the dollar in recent weeks continues. The greenback hit new lows for the year against both the franc and the euro on Tuesday.
This content was published on
Swiss President Karin Keller-Sutter has met French President Emmanuel Macron to discuss the EU treaties and geopolitical challenges. US tariffs were also part of the bilateral talks.
This content was published on
Swiss moors and floodplains are in a poor state. Researchers say further efforts are needed to preserve these biotopes in the long term.
Drones banned during the three Euro games in St Gallen
This content was published on
The St. Gallen government has issued a temporary ban on flying drones around the football stadium in St. Gallen. The measure will apply on three match days of Euro 2025, which starts on Wednesday.
EU nationals come to Switzerland primarily to work
This content was published on
Given the demographic slowdown, the Swiss labour market must remain open, argues the State Secretariat for Economic Affairs (SECO) in its annual report on the free movement of people.
UN expert accuses Glencore of complicity with Israel
This content was published on
The UN Special Rapporteur on the Palestinian Territories has accused Zug-based Glencore of profiting from an Israeli economy that has become "an economy of genocide".
Swiss parliamentary commission to investigate F-35 purchase
This content was published on
The Swiss government and the other responsible authorities must once again answer critical questions about the procurement of the F-35 fighter jets.
Objections and appeals most common obstacles to residential construction projects
This content was published on
Objections and appeals are most frequently responsible for delays in new residential construction projects in Switzerland.
Swiss electricity prices predicted to fall in 2026
This content was published on
Electricity prices in 2026 are likely to be lower than this year, according to a survey. The main reason is the fall in prices on the electricity market.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Novartis and Microsoft to develop drugs using AI
This content was published on
Novartis and Microsoft have signed a five-year partnership aimed at transforming the Basel-based pharma’s business using AI.
Gaps found in opioid prescription oversight in Switzerland
This content was published on
In the wake of the opioid crisis in the US, some medical professionals in Switzerland are warning about over-prescription of oxycodone drugs.
Swiss pharmaceutical firm lets dogs die cruel death
This content was published on
Dogs are being left to die in agony in Germany after lab testing for the Swiss pharma company Inthera Bioscience, says a report.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.